On this page: Medicines committees | Medical devices committees | Other committees

Medicines committees

• Adverse Drug Reactions Advisory Committee (ADRAC)
  The Adverse Drug Reactions Advisory Committee (ADRAC) was a subcommittee of the Australian Drug Evaluation Committee (ADEC), formed in 1970 to advise the TGA on the safety of medicines
• Advisory Committee on Non-prescription Medicines (ACNM)
  The ACNM advised and made recommendations regarding the entry of non-prescription medicines on the ARTG
• Advisory Committee on Prescription Medicines (ACPM)
  The ACPM advised and made recommendations regarding the entry of prescription medicines on the ARTG
• Advisory Committee on the Safety of Medicines (ACSOM)
  The ACSOM made recommendations on the safety of medicines and risk assessment and risk management of medicines
• Advisory Committee on the Safety of Vaccines (ACSOV)
  The ACSOV advised and mades recommendations on the safety, risk assessment and risk management of vaccines
• Australian Drug Evaluation Committee (ADEC)
  The Australian Drug Evaluation Committee (ADEC) was formed to provide independent, scientific advice on new drugs, within the policy framework of the time
• Complementary Medicines Evaluation Committee (CMEC)
  The Complementary Medicines Evaluation Committee (CMEC) provided scientific and policy advice relating to controls on the supply and use of complementary medicines
• Expert Committee on Complementary Medicines in the Health System
  To reassure the public and maintain confidence in Australia's reputation as a supplier of high quality and safe medicines, the Australian Government established the Expert Committee on Complementary Medicines in the Health System in May 2003
• Fifty years of independent expert advice on prescription medicines
  This booklet highlights a number of the significant achievements of the ADEC and its successor, the Advisory Committee on Prescription Medicines (ACPM), in facilitating and enabling access to new medicines and in preventing the introduction of medicines that are ineffective or have major safety problems
• Medicines Evaluation Committee (MEC)
  The Medicines Evaluation Committee (MEC) provided independent scientific and policy advice on OTC medicines

Medical devices committees

• Advisory Committee on the Safety of Medical Devices (ACSMD)
  The ACSMD advised and made recommendations on the safety, risk assessment, risk management and performance of medical devices supplied in Australia
• Medical Devices Evaluation Committee (MDEC)
  The Medical Device Evaluation Committee (MDEC) provided independent medical and scientific advice on the safety, quality and performance of medical devices supplied in Australia
• Therapeutic Device Evaluation Committee (TDEC)
  The Therapeutic Device Evaluation Committee (TDEC) provided independent medical and scientific advice on the safety, quality and performance of medical devices supplied in Australia

Other committees

• Australian Therapeutic Goods Advisory Committee
  The Council provided strategic advice to the TGA on matters relating to organisational planning, management initiatives, performance measures and quality improvement, including service standards and benchmarking
• National Coordinating Committee on Therapeutic Goods (NCCTG)
  The functions of the Committee were to take action necessary to bring about co-ordination of legislative and administrative controls on therapeutic goods and poisons and to make recommendations to the Australian Health Ministers' Advisory Council as necessary.
• National Drugs and Poisons Schedule Committee (NDPSC)
  The National Drugs and Poisons Schedule Committee (NDPSC) was established under section 52B of the Therapeutic Goods Act 1989
• Therapeutic Goods Committee (TGC)
  The TGC advised the Minister on standards for therapeutic goods, including labelling and packaging, and on principles to be observed in the manufacture of therapeutic goods for use in humans